No consumer wearable diagnoses a sleep disorder. Diagnosis requires clinical evaluation, and for sleep-disordered breathing, an FDA-cleared home sleep apnea test or in-laboratory polysomnography interpreted by a qualified physician.
What wearables can legitimately contribute
- Objective sleep timing and regularity across weeks, which supports circadian assessment.
- Screening signals — for example, oxygen desaturation patterns that warrant referral.
- Adherence and behavior data during treatment.
- Engagement: many people seek care because a device prompted them to.
Why the distinction matters
A cleared screening feature that flags "possible breathing disturbances" is not equivalent to an apnea-hypopnea index. Acting on tracker output alone risks both false reassurance — a normal-looking score in someone with significant apnea — and unnecessary alarm. The appropriate use is as a prompt to seek evaluation, not as the evaluation.
For product teams, the design implication is the same: build for referral and triage, be explicit about validation, and separate regulated claims from wellness features.
Written and reviewed by Christine Mason, PhD, DBSM, health psychologist board-certified in behavioral sleep medicine. Published August 25, 2026. Last reviewed August 25, 2026.
Related reading